Dr. Liping Zhao, of Shanghai Jiao Tong University, is at the cutting edge of research on how the gut microbiota influence obesity.
Dr. Premysl Bercik is a gastroenterologist, researcher, and Associate Professor in the Division of Gastroenterology at McMaster University in Canada.
Fecal microbiota transplantation for conditions other than C. difficile: Science or pretense?
20 May 2015by Kristina Campbell
Fecal microbiota transplantation (FMT), which is up to 90% effective in treating recurrent Clostridium difficile (C. difficile) infection, may or may not be an effective treatment for other conditions.
Further investigation of fecal microbiota transplantation to treat ulcerative colitis
12 May 2015by Paul Enck
Amsterdam researchers recently published an investigation of fecal microbiota transplantation (FMT) for the treatment of ulcerative colitis (UC).
New Study Investigating Fecal Microbiota Transplantation to Treat Active Ulcerative Colitis
14 Apr 2015by Paul Enck
Moayyedi et al. from Canada recently published a paper entitled Fecal Microbiota Transplantation Induces Remission in Patients with Active Ulcerative Colitis in a Randomized, Controlled Trial.
Mark Smith of OpenBiome: Should Scientists Step Up to Supervise Patients Who Self-Administer Fecal Microbiota Transplants?
21 Mar 2015by Kristina Campbell
Dr. Mark Smith is a postdoctoral associate at Massachusetts Institute of Technology and co-founder of OpenBiome, a nonprofit organization focused on expanding safe access to fecal microbiota transplantation (FMT).
Interview with Dr. Brent Polk, on inflammatory bowel disease in childhood
16 Feb 2015by Kristina Campbell
Dr. D. Brent Polk is a physician and professor of biochemistry & molecular biology. He is chair of the Department of Pediatrics at Children’s Hospital Los Angeles, as well as chair of pediatrics and vice dean for Child Health at the Keck School of Medicine of the University of Southern California.
Neha Alang and Colleen R. Kelly recently reported that a patient who had received fecal microbiota transplantation (FMT) developed obesity (1).
Dr. Faming Zhang, on treating refractory Crohn’s disease with fecal microbiota transplantation
12 Jan 2015by Kristina Campbell
Dr. Faming Zhang, MD, PhD, is a doctor and researcher at the Institute for Digestive Endoscopy & Medical Center for Digestive Diseases at The Second Affiliated Hospital of Nanjing Medical University in Nanjing, China. He is Vice Chief of the Medical Center for Digestive Diseases, and Director of Intestinal Diseases.
Interview with Dr. James Versalovic, children’s microbiome researcher
8 Sep 2014by Kristina Campbell
Dr. James Versalovic, M.D., Ph.D, is the director of the Texas Children's Hospital Microbiome Center and head of the Pediatric Infectious Diseases Section. He is also a professor at Baylor College of Medicine. As the Gut Microbiota for Health expert on research tools, Dr. Versalovic spoke with
